Use of micro-positron emission tomography with ¹⁸F-fallypride to measure the levels of dopamine receptor-D2 and ¹⁸F-FDG as molecular imaging tracer in the pituitary glands and prolactinomas of Fischer-344 rats

References

• JiangXZhangXThe molecular pathogenesis of pituitary adenomas: an updateEndocrinol Metab (Seoul)201328424525424396688
   PubMedGoogle Scholar
• OhMCAghiMKDopamine agonist-resistant prolactinomasJ Neurosurg201111451369137921214334
   PubMed Web of Science ®Google Scholar
• KlibanskiADopamine agonist therapy in prolactinomas: when can treatment be discontinued?J Clin Endocrinol Metab20099472247224919584197
   PubMed Web of Science ®Google Scholar
• MolitchMEDopamine resistance of prolactinomasPituitary200361192714674720
   PubMedGoogle Scholar
• ColaoAdi SarnoAPivonelloRdi SommaCLombardiGDopamine receptor agonists for treating prolactinomasExpert Opin Investig Drugs2002116787800
   PubMed Web of Science ®Google Scholar
• GattoFHoflandLJThe role of somatostatin and dopamine D2 receptors in endocrine tumorsEndocr Relat Cancer2011186R233R25122135243
   PubMed Web of Science ®Google Scholar
• RamakrishnanNKRybczynskaAAVisserAKSmall-animal PET with a sigma-ligand, 11C-SA4503, detects spontaneous pituitary tumors in aged ratsJ Nucl Med20135481377138323785170
   PubMed Web of Science ®Google Scholar
• MukherjeeJYangZYDasMKBrownTFluorinated benzamide neuroleptics – III. Development of (S)-N-[(1-allyl-2-pyrrolidinyl) methyl]-5-(3-[18F]fluoropropyl)-2, 3-dimethoxybenzamide as an improved dopamine D-2 receptor tracerNucl Med Biol19952232832967627142
   PubMed Web of Science ®Google Scholar
• MilletPMoulin-SallanonMTournierBBQuantification of dopamine D(2/3) receptors in rat brain using factor analysis corrected [18F]Fallypride imagesNeuroimage20126231455146822659483
   PubMed Web of Science ®Google Scholar
• WiklundJWertzNGorskiJA comparison of estrogen effects on uterine and pituitary growth and prolactin synthesis in F344 and Holtzman ratsEndocrinology19811095170017077297500
   PubMed Web of Science ®Google Scholar
• PiroliGGPietraneraLGrilloCADe NicolaAFGender differences in the expression of galanin and vasoactive intestinal peptide in oestrogen-induced prolactinomas of Fischer 344 ratsJ Neuroendocrinol2004161647114962078
   PubMed Web of Science ®Google Scholar
• HeaneyAPHorwitzGAWangZSingsonRMelmedSEarly involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesisNat Med19995111317132110546001
   PubMed Web of Science ®Google Scholar
• ZhouGJJiangSYZhangMGanJXJiangGYEvaluation of the inflammatory response in a two-hit acute lung injury model using [F] FDG microPETExp Ther Med20136489489824137285
   PubMed Web of Science ®Google Scholar
• WangMWLinWYLiuKMasterman-SmithMKwang-Fu ShenCMicrofluidics for positron emission tomography probe developmentMol Imaging20109417519120643021
   PubMed Web of Science ®Google Scholar
• BodeiLHoflandLJFeroneDIn vivo and in vitro detection of dopamine d2 receptors in uveal melanomasCancer Biother Radiopharm200318689590214969602
   PubMed Web of Science ®Google Scholar
• RecouvreuxMVGuidaMCRifkinDBBecu-VillalobosDDiaz-TorgaGActive and total transforming growth factor-beta1 are differentially regulated by dopamine and estradiol in the pituitaryEndocrinology201115272722273021521749
   PubMed Web of Science ®Google Scholar
• SchuffKGHentgesSTKellyMALack of prolactin receptor signaling in mice results in lactotroph proliferation and prolactinomas by dopamine-dependent and -independent mechanismsJ Clin Invest2002110797398112370275
   PubMed Web of Science ®Google Scholar
• SenguptaASarkarDKEstrogen inhibits D2S receptor-regulated Gi3 and Gs protein interactions to stimulate prolactin production and cell proliferation in lactotropic cellsJ Endocrinol20122141677822573829
   PubMed Web of Science ®Google Scholar
• Levavi-SivanBBiranJFiremanESex steroids are involved in the regulation of gonadotropin-releasing hormone and dopamine D2 receptors in female tilapia pituitaryBiol Reprod200675464265016807382
   PubMed Web of Science ®Google Scholar
• MooreJWSchneiderSASchwingenschuhPDopaminergic medication boosts action-effect binding in Parkinson’s diseaseNeuropsychologia20104841125113220018200
   PubMed Web of Science ®Google Scholar
• Garcia-TornaduIPerez-MillanMIRecouvreuxVNew insights into the endocrine and metabolic roles of dopamine D2 receptors gained from the Drd2 mouseNeuroendocrinology201092420721420975260
   PubMed Web of Science ®Google Scholar
• FilopantiMLaniaAGSpadaAPharmacogenetics of D2 dopamine receptor gene in prolactin-secreting pituitary adenomasExpert Opin Drug Metab Toxicol201061435319929252
   PubMed Web of Science ®Google Scholar
• OzturkHKarapolatIEfficacy of F-fluorodeoxyglucose-positron emission tomography/computed tomography in restaging muscle-invasive bladder cancer following radical cystectomyExp Ther Med20159371772425667618
   PubMed Web of Science ®Google Scholar
• NordMFardeLAntipsychotic occupancy of dopamine receptors in schizophreniaCNS Neurosci Ther20111729710321143431
   PubMed Web of Science ®Google Scholar
• MuhrCBergstromMLundbergPODopamine receptors in pituitary adenomas: PET visualization with 11C-N-methylspiperoneJ Comput Assist Tomogr19861021751803485123
   PubMed Web of Science ®Google Scholar
• MuhrCBergstromMPositron emission tomography applied in the study of pituitary adenomasJ Endocrinol Invest19911465095281837798
   PubMed Web of Science ®Google Scholar
• Abi-DarghamARodenhiserJPrintzDIncreased baseline occupancy of D2 receptors by dopamine in schizophreniaProc Natl Acad Sci U S A200097148104810910884434
   PubMed Web of Science ®Google Scholar
• LuoMLiQDongWZhaiXKangLEvaluation of mild hypothermia therapy for neonatal hypoxic-ischaemic encephalopathy on brain energy metabolism using F-fluorodeoxyglucose positron emission computed tomographyExp Ther Med2014841219122425187828
   PubMed Web of Science ®Google Scholar
• ZhaoXXiaoJXingBComparison of 68Ga DOTATATE to 18F-FDG uptake is useful in the differentiation of residual or recurrent pituitary adenoma from the remaining pituitary tissue after transsphenoidal adenomectomyClin Nucl Med201439760560824873787
   PubMed Web of Science ®Google Scholar